These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 37711822
1. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence. Li Y, Yang Z, Lv W, Qin Y, Tang C, Yan X, Yin T, Ai T, Xia L. Quant Imaging Med Surg; 2023 Sep 01; 13(9):5974-5985. PubMed ID: 37711822 [Abstract] [Full Text] [Related]
2. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment. Li Y, Chen J, Yang Z, Fan C, Qin Y, Tang C, Yin T, Ai T, Xia L. J Magn Reson Imaging; 2023 Sep 01; 58(3):963-974. PubMed ID: 36738118 [Abstract] [Full Text] [Related]
6. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value? Li X, Wang H, Gao J, Jiang L, Chen M. Quant Imaging Med Surg; 2023 Oct 01; 13(10):7092-7104. PubMed ID: 37869329 [Abstract] [Full Text] [Related]
8. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes. Ochi M, Kuroiwa T, Sunami S, Murakami J, Miyahara S, Nagaie T, Oya M, Yabuuchi H, Hatakenaka M. Breast Cancer; 2013 Apr 01; 20(2):137-44. PubMed ID: 22161277 [Abstract] [Full Text] [Related]
13. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS. Gao W, Zhang S, Guo J, Wei X, Li X, Diao Y, Huang W, Yao Y, Shang A, Zhang Y, Yang Q, Chen X. J Magn Reson Imaging; 2021 Apr 01; 53(4):1118-1127. PubMed ID: 33179809 [Abstract] [Full Text] [Related]